Lycium barbarum Polysaccharide Ameliorates Hindlimb Unloading‐Induced Bone Loss by Targeting Noggin
The FASEB Journal · 2025
DOI: 10.1096/fj.202403082r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Chuanxin Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Bio…. Hauptthemen laut MEDLINE: Lycium, Polysaccharides, Hindlimb, Bone Diseases, Metabolic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Regional Key Projects of Science anf Technology Service Network Plan of the Chinese Academy of Sciences, National Key Research and Development Program of China.
Abstract (Originalsprache)
Disuse bone loss is a common metabolic bone disease with limited effective, safe treatments. Lycium barbarum ( L. barbarum ), a traditional Chinese medicine and popular health food, has been historically noted in Ben Cao Gang Mu (Compendium of Materia Medica) for its bone‐strengthening properties. However, the effects of L. barbarum on disuse bone loss and the underlying mechanisms remain unclear. This study used a hindlimb‐unloading mouse model and a simulated microgravity model of MC3T3‐E1 cells in a rotary cell culture system to investigate the role of L. barbarum water extract (LBE) and polysaccharide (LBP). LBE and LBP significantly enhanced bone mass and strength in hindlimb‐unloaded mice. Further analysis identified a polysaccharide component, LBPP, as the active ingredient mediating these effects. LBPP enhanced osteoblast differentiation and ossification under normal conditions and promoted osteoblast activity under simulated microgravity. Mechanistic studies revealed that LBPP directly binds to noggin, a potent inhibitor of BMPs, facilitating phosphorylation of downstream Smads to stimulate bone formation. These findings demonstrate the potential of L. barbarum as a functional food for preventing disuse bone loss and provide a theoretical basis for its therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People's Republic of Ch…
- University of Chinese Academy of Sciences, Beijing, People's Republic of China.
- CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Science, SSIP Healthcare and Medicine Demonstration Zone, Zhongshan, Guangdong, People's Republic of China.
- Beijing Institute for Brain Disorders Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Chuanxin Sun, Chang Chen
Förderung
- Beijing Natural Science Foundation
- Regional Key Projects of Science anf Technology Service Network Plan of the Chinese Academy of Sciences
- National Key Research and Development Program of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Key Research and Development Program of Ningxia
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Sun, C., He, Y., Chen, X., Ding, K., & Chen, C. (2025). Lycium barbarum Polysaccharide Ameliorates Hindlimb Unloading‐Induced Bone Loss by Targeting Noggin. The FASEB Journal. https://doi.org/10.1096/fj.202403082r
Vancouver
Sun C, He Y, Chen X, Ding K, Chen C. Lycium barbarum Polysaccharide Ameliorates Hindlimb Unloading‐Induced Bone Loss by Targeting Noggin. The FASEB Journal. 2025. doi:10.1096/fj.202403082r
BibTeX
@article{Sun2025,
author = {Sun, Chuanxin and He, Yuke and Chen, Xia and Ding, Kan and Chen, Chang},
title = {Lycium barbarum Polysaccharide Ameliorates Hindlimb Unloading‐Induced Bone Loss by Targeting Noggin},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403082r}
}
EUVIMED